Press release
Anti-Infective Agents Market Size is Projected to Reach US$ 195.8 Billion by 2035 With a CAGR of 2.6% | Fact.MR
Anti-Infective Agents Market
The steady increase in antimicrobial resistance, combined with a growing infectious disease burden across the globe, is serving as a key driver for long-term demand. Besides that, growing government and private investment in developing antibiotics, particularly in emerging and developing economies, is promoting sustainable development in the global pharma sector.
For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8045
Market Analysis
The industry is developing steadily, driven by worldwide AMR needs, ramped-up R&D spendings, and high-priority anti-infectives regulation by authorities. Regional players and pharma innovators benefit, with low-margin generics threatened by escalating price and compliance pressure.
Country-wise Analysis
The U.S. market for anti-infective agents will expand at a 6.8% CAGR over the forecast period. The widespread incidence of infectious diseases, global prevalence of antimicrobial resistance, and ongoing demand for new anti-infective therapy propel growth. The U.S. pharma industry has one of the most sophisticated pharma environments in terms of high R&D investment.
The UK anti-infective agents market will have a 5.9% CAGR over the study period. Government-supported surveillance programs and infection control strategies are the backbone of the UK anti-infective agents market growth.
The German anti-infective agents market will witness a growth at 6.0% CAGR over the study period. A well-established healthcare infrastructure, robust healthcare spending, and robust pharmaceutical R&D capabilities fuel the growth.
The Chinese market for anti-infective agents is predicted to rise at 7.4% CAGR over the forecast period. China is experiencing accelerated healthcare evolution with government investment, urbanization, and increasing middle-class demographics with access to quality healthcare. The nation has stepped up nationwide campaigns against the abuse of antibiotics and the sale of antibiotics over the counter, with stricter regulatory oversight of anti-infective drug distribution.
Segment-wise Analsysis
By Type :
By 2025, the market for anti-infective agents will be led by the antiviral segment, which will hold the largest 51% market share compared to antibacterial agents' 30%. Evidently, the trend reflects the global world's healthcare priorities as viral threats persistently emerge and re-emerge, impacting public health systems.
By Range :
By type, broad-spectrum agents dominate the market for anti-infective agents with a 60% market share compared to the other 40% market share of narrow-spectrum agents. This pattern confirms the ongoing preference by clinicians towards therapeutics, which provides broad activity against a spectrum of pathogens, particularly when in the context of acute and empiric treatment.
Competitive Outlook
Anti-infective agents market is extensive and competitive where global pharmaceuticals giants are betting on broad-spectrum antibiotics together with antiviral and antifungal therapeutics. Large R&D pipeline, regulatory milestones, and symbiotic strategic collaborative partnerships with biotech firms, the major stalwarts are GlaxoSmithKline, Pfizer, and Bayer AG.
Sanofi, Merck Co. and Bristol-Myers Squibb form a robust industry presence with future-generation anti-infectives, such as combination therapies that employ new mechanisms targeting resistant pathogens. These firms are enhancing their drug portfolios through strategic acquisitions and licensing deals, expanding their portfolios in infectious disease treatment.
Abbott, Novartis, and Johnson and Johnson have actually concentrated their investments in antiviral innovation, such as creating therapies for HIV and hepatitis C, and expanded their penetration across the globe by partnering with public health entities and governments in expanding access to their critical medicines, as well as better investment in developing diagnostics, vaccines, and precision medicine strategies. These heightened cases of incurability of multi-drug-resistant infection have prompted these firms to invest more in rapid diagnostics, vaccines, and precision medicine strategies.
Browse Full Report: https://www.factmr.com/report/anti-infective-agents-market
Key Players
GlaxoSmithKline plc.
Pfizer Inc.
Bayer AG
Sanofi
Merck & Co., Inc.
Bristol-Myers Squibb Company
Abbott
Novartis AG
Johnson & Johnson Services Inc.
Gilead Sciences, Inc.
Astellas Pharma Inc.
Segmentation
By Type :
Antiviral
Antibacterial
Antifungal
Others
By Range :
Narrow Spectrum
Broad Spectrum
By Route of Administration :
IV
Oral
Topical
Others
By Indication :
HIV
Tuberculosis
Respiratory Infection
Pneumonia
Others
By Distribution Channel :
Hospital Pharmacies
Retail Pharmacies
Specialty Pharmacies
E-Commerce
Others
By Region :
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa (MEA)
Check out More Related Studies Published by Fact.MR:
Breathalyzer Market
https://www.factmr.com/report/125/breathalyzer-market
Radiotherapy Devices Market
https://www.factmr.com/report/77/radiotherapy-devices-market
Cardiac POC Testing Devices Market
https://www.factmr.com/report/cardiac-poc-testing-devices-market
Kidney Dialysis Equipment and Supplies Market
https://www.factmr.com/report/kidney-dialysis-equipment-and-supplies-market
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-Infective Agents Market Size is Projected to Reach US$ 195.8 Billion by 2035 With a CAGR of 2.6% | Fact.MR here
News-ID: 3977239 • Views: …
More Releases from Fact.MR
Vanilla Extract Industry Analysis in South Asia & Oceania Growth to Reach US$ 91 …
The Revenue of vanilla extract industry in South Asia & Oceania is expected to grow from US$ 433.7 million in 2024 to US$ 910.64 million by 2034, at a 7.7% CAGR.
Vanilla orchids, which produce vanilla beans, are cultivated primarily in tropical areas with specific soil and environmental conditions. Tahiti, Madagascar, and Comoros are some of the key areas that produce most of the world's vanilla.
For More Insights into the Market,…
Air Treatment Product Market Size Expected to Reach US$ 166.21 Billion by 2034: …
The size of the global air treatment products market has been estimated to grow to US$ 62.36 billion in 2024 and reach US$ 166.21 billion by the end of 2034. Demand for air treatment products at the global level is anticipated to grow at a healthy CAGR of 10.3% during 2024-2034.
Air treatment products is a group of products and equipment that aim to enhance or sustain the indoor air quality.…
Newborn Metabolic Screening Market is Predicted to Reach US$ 857.4 Billion by 20 …
The size of the newborn metabolic screening market is expected to reach US$ 355.1 million in 2024. A high compound annual growth rate (CAGR) of 9.2% is expected to drive the market through 2034. This upward trend is estimated to drive the market to a high value of US$ 857.4 million by 2034.
As knowledge of metabolic disorders that impact infants has increased, so too has the use of newborn metabolic…
Neuropathic Pain Market Size Worth US$ 14,538.7 Million by 2034 at a CAGR of 5.7 …
The size of the neuropathic pain market was approximately US$ 6,316.6 million in 2019. The net value of the neuropathic drugs to be retailed together with the nerve pain relief services is expected to be approximately US$ 8,382.9 million in 2024. The demand for the neuropathic pain relief medicines and services globally is expected to experience a CAGR of 5.7% during 2034. The industry is expected to be valued at…
More Releases for CAGR
Cat Litter Box Market | CAGR of 9.1% | Revenue & CAGR of 9.1%
Cat Litter Box Market Report provides precise data about the market size, commercialization aspects and revenue forecast of the industry. The global Cat Litter Box market offers a historical factsheet relevant to the strategic mergers, acquirements, joint venture activities, and partnerships spread in the Cat Litter Box market. The most advanced data has been presented in the study on the revenue numbers, product details, and sales of the major firms.…
Predictive Analytics Market Growing at Strong CAGR of CAGR of 25.31% 2019
Predictive analytics helps to extract information from the existing data. It helps in understanding the pattern and predict the trend or future for the organization. It uses what-if scenarios to predict possible risks involved in the future. Predictive analytics also helps in the optimization of the marketing campaigns and understanding of the customer behaviour for increasing the end-user response and to reduce the churn.
Predictive analytics is segmented into:
Risk management:…
Global Absorption Chillers Market Reflecting a CAGR of 7.6% CAGR through 2025
The demand for thermally-driven chillers in multiple industrial verticals is poised to grow in the immediate future. Considering the rising demand for electrical chillers in commercial, residential as well as industrial settings, the adoption of absorption chillers will gain traction at considerable rate. By consuming lesser energy than conventional electrical chillers, absorption chillers will also garner surplus demand for not using ozone-depleting chlorofluorocarbons (CFC) for chilling purposes. Persistence Market Research’s…
Aircraft Sensors Market Growing at a CAGR of 6.4% CAGR By 2022
The global aircraft sensors market is forecasted to receive a strong push in its growth momentum on the back of advancements in technologies, massive investments forwarded by private equity groups, and the elevation in the demand for aircraft. Adherence to the requirements and regulations of authorities such as local aircraft regulatory bodies and the Federal Aviation Administration (FAA) could pamper the growth of the market. Nonetheless, there could be more…
China Baby Diapers Market Reflecting a CAGR of 19.1% CAGR 2012-2017
The increasing birth rate in China has proven to be a boon for the country’s baby diaper’s market. To provide a comprehensive analysis of the growth trajectory exhibited by the China baby diapers market and study the impact of the dynamic regulatory policies on the market, Transparency Market Research (TMR) has published a report, titled “Baby Diapers Market - China Industry Analysis, Market Size, Share, Growth, Trends And Forecast, 2012…
Ecg Device Market Register a CAGR Growth of 4.1% CAGR by 2024
This region holds highest market share over the forecast period (2016-2024) and is expected to exhibit slow growth rate. The Asia Pacific is expected to be the fastest-growing region for ECG devices owing to its increasing incidence rate of cardiovascular diseases and high population.
ECG devices are experiencing a paradigm technological shift from resting ECG systems to portable Holter monitoring systems, owing to their advantages of patient mobility, low prices and…
